We are dedicated to ensuring that your discoveries have the right dosage forms. As we work with you to build your program, we are focused on providing speed, flexibility, and efficiency to accelerate your molecule’s journey to FIH studies. Our offering includes:
In 2019 alone, we produced 132 million sterile liquid and lyo vials. We also development and manufactured 40 different pharmaceutical dosage forms, addressing 72 percent of all dosage forms approved. With traditional or niche indications in drug development for steriles, Thermo Fisher understands the unique set of challenges that arise—we offer a broad range of dosage forms to meet your large molecule’s needs:
Download our full Dosage Form brochure.